96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo

by Sara Brett, Aiman Shalabi, Dmitry Pankov, Ioanna Eleftheriadou, Anna Domogala, Lea Patasic, Magdalena Kijewska, Gary Thripp, Jack Euesden, Jan Klapwijk, Katrina Soor, Miriam Damm, Mark D Hill, Mirella Georgouli, Cedrik Britten
Published 2020-11-01